O’Connor KC, McLaughlin KA, De Jager PL, Chitnis T, Bettelli E, Xu C, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med. 2007;13(2):211–7. https://doi.org/10.1038/nm1488.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ciotti JR, Eby NS, Wu GF, Naismith RT, Chahin S, Cross AH. Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica. Mult Scler Relat Disord. 2020;45:102399. https://doi.org/10.1016/j.msard.2020.102399.

Article  PubMed  Google Scholar 

•• Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;22(3):268–82. https://doi.org/10.1016/S1474-4422(22)00431-8. (This proposed diagnostic criteria, as determined by an international panel of neuroimmunology experts, defines MOG antibody disease and accounts for common clinical presentations and MOG antibody titers.)

Article  CAS  PubMed  Google Scholar 

Johns TG, Bernard CC. The structure and function of myelin oligodendrocyte glycoprotein. J Neurochem. 1999;72(1):1–9. https://doi.org/10.1046/j.1471-4159.1999.0720001.x.

Article  CAS  PubMed  Google Scholar 

Peschl P, Bradl M, Höftberger R, Berger T, Reindl M. Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases. Front Immunol. 2017;8(8):529. https://doi.org/10.3389/fimmu.2017.00529.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Corbali O, Chitnis T. Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Front Neurol. 2023;14:1137998. https://doi.org/10.3389/fneur.2023.1137998. (This review comprehensively summarizes the pathophysiology of MOG antibody disease, which offers insight into its unique clinical and radiologic features.)

Article  PubMed  PubMed Central  Google Scholar 

Lebar R, Boutry JM, Vincent C, Robineaux R, Voisin GA. Studies on autoimmune encephalomyelitis in the guinea pig. II. An in vitro investigation on the nature, properties, and specificity of the serum-demyelinating factor. J Immunol. 1976;116(5):1439–46.

Article  CAS  PubMed  Google Scholar 

Linington C, Lassmann H. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J Neuroimmunol. 1987;17(1):61–9. https://doi.org/10.1016/0165-5728(87)90031-2.

Article  CAS  PubMed  Google Scholar 

Schluesener HJ, Sobel RA, Linington C, Weiner HL. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol. 1987;139(12):4016–21.

Article  CAS  PubMed  Google Scholar 

Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 2012;11(6):535–44. https://doi.org/10.1016/S1474-4422(12)70133-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mariotto S, Ferrari S, Monaco S, Benedetti MD, Schanda K, Alberti D, et al. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study. J Neurol. 2017;264(12):2420–30. https://doi.org/10.1007/s00415-017-8635-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;20(5):520. https://doi.org/10.3389/fimmu.2014.00520.

Article  CAS  Google Scholar 

Majed M, Fryer JP, McKeon A, Lennon VA, Pittock SJ. Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians. Neurol Neuroimmunol Neuroinflamm. 2016;3(3):e231. https://doi.org/10.1212/NXI.0000000000000231.

Article  PubMed  PubMed Central  Google Scholar 

Pace S, Orrell M, Woodhall M, Palace J, Leite MI, Irani SR, et al. Frequency of MOG-IgG in cerebrospinal fluid versus serum. J Neurol Neurosurg Psychiatry. 2022;93(3):334–5. https://doi.org/10.1136/jnnp-2021-326779.

Article  PubMed  Google Scholar 

Höftberger R, Guo Y, Flanagan EP, Lopez-Chiriboga AS, Endmayr V, Hochmeister S, et al. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol. 2020;139(5):875–92. https://doi.org/10.1007/s00401-020-02132-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yandamuri SS, Filipek B, Obaid AH, Lele N, Thurman JM, Makhani N, et al. MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity. JCI Insight. 2023;8(11):e165373. https://doi.org/10.1172/jci.insight.165373.

Article  PubMed  PubMed Central  Google Scholar 

Kinzel S, Lehmann-Horn K, Torke S, Häusler D, Winkler A, Stadelmann C, et al. Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen. Acta Neuropathol. 2016;132(1):43–58. https://doi.org/10.1007/s00401-016-1559-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

• de Mol CL, Wong Y, van Pelt ED, Wokke B, Siepman T, Neuteboom RF, et al. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler. 2020;26(7):806–14. https://doi.org/10.1177/1352458519845112. (This national registry study helps to define the incidence and clinical spectrum of MOGAD.)

Article  CAS  PubMed  Google Scholar 

O’Connell K, Hamiton-Shield A, Woodhall M, Messina S, Mariano R, Waters P, et al. Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire. UK J Neurol Neurosurg Psychiatry. 2020;91(10):1126–8. https://doi.org/10.1136/jnnp-2020-323158.

Article  PubMed  Google Scholar 

Hor JY, Fujihara K. Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide. Front Neurol. 2023;15(14):1260358. https://doi.org/10.3389/fneur.2023.1260358.

Article  Google Scholar 

Bruijstens AL, Wong YYM, van Pelt DE, van der Linden PJE, Haasnoot GW, Hintzen RQ, et al. HLA association in MOG-IgG- and AQP4-IgG-related disorders of the CNS in the Dutch population. Neurol Neuroimmunol Neuroinflamm. 2020;7(3):e702. https://doi.org/10.1212/NXI.0000000000000702.

Article  PubMed  PubMed Central  Google Scholar 

Nakamura M, Ogawa R, Fujimori J, Uzawa A, Sato Y, Nagashima K, et al. Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey. Mult Scler. 2023;29(4–5):530–9. https://doi.org/10.1177/13524585231156736.

Article  CAS  PubMed  Google Scholar 

Akaishi T, Fujimori J, Takahashi T, Misu T, Takai Y, Nishiyama S, et al. Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody. J Neuroimmunol. 2020;15(349):577431. https://doi.org/10.1016/j.jneuroim.2020.577431.

Article  CAS  Google Scholar 

Orlandi R, Mariotto S, Gajofatto A. Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona. Italy Mult Scler Relat Disord. 2022;63:103884. https://doi.org/10.1016/j.msard.2022.103884.

Article  PubMed  Google Scholar 

Lambe J, McGinley MP, Moss BP, Mao-Draayer Y, Kassa R, Ciotti JR, et al. Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series. J Neuroimmunol. 2022;15(370):577933. https://doi.org/10.1016/j.jneuroim.2022.577933.

Article  CAS  Google Scholar 

Boudjani H, Fadda G, Dufort G, Antel J, Giacomini P, Levesque-Roy M, et al. Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler Relat Disord. 2023;76:104787. https://doi.org/10.1016/j.msard.2023.104787.

Article  CAS  PubMed  Google Scholar 

Kunchok A, Flanagan EP, Snyder M, Saadeh R, Chen JJ, Weinshenker BG, et al. Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD. Mult Scler. 2021;27(4):630–5. https://doi.org/10.1177/1352458520933884.

Article  CAS